SARS-CoV-2 Fulminant Myocarditis

Jérôme Garot; Julien Amour; Théo Pezel; Firas Dermoch; Kamel Messadaa; Marie-Louise Felten; Valérie Raymond; Eric Baubillier; Francesca Sanguineti; Philippe Garot

doi:10.1016/j.jaccas.2020.05.060

SARS-CoV-2 Fulminant Myocarditis

JACC Case Rep. 2020 Jul 15;2(9):1342-1346. doi: 10.1016/j.jaccas.2020.05.060. Epub 2020 Jun 5.

Authors

Affiliations

¹ Cardiovascular Magnetic Resonance Laboratory, Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
² Covid-19-Intensive Care Unit #2, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.

Abstract

An 18-year-old male without prior medical history developed fulminant myocarditis concomitant to severe COVID-19 pneumonia, which was confirmed using serial cardiac magnetic resonance. This may have important diagnostic, monitoring, and pathogenic implications. (Level of Difficulty: Intermediate.).

Keywords: COVID-19, coronavirus disease-2019; EF, ejection fraction; EGE, early gadolinium enhancement; LGE, late gadolinium enhancement; LV, left ventricle; LVEF, left ventricular ejection fraction; SARS-CoV-19, severe acute respiratory syndrome-coronavirus-2019; cardiac magnetic resonance; coronavirus disease 2019; myocarditis.

Publication types

Case Reports